Suppr超能文献

局部用替巴替尼治疗光化性角化病的疗效。

[Efficacy of topical tirbanibulin in treating actinic keratosis.].

作者信息

Villani Alessia

机构信息

Dermatologia Clinica, Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Napoli.

出版信息

Recenti Prog Med. 2024 Oct;115(10):46e-47e. doi: 10.1701/4357.43477.

Abstract

Actinic keratoses (AK) are common precancerous lesions usually arising on chronic sun-exposed areas. Field of cancerization (FC) is a chronically UV-exposed area in which subclinical multifocal AKs are found. Therapeutic choice is mainly made according to the Olsen grade of AKs. We report the case of a 76-year-old man with numerous AKs of the face and scalp. The patient had undergone numerous topical physical and medical therapies with poor results. On the left cheek, grade I and grade II AKs were found in a large FC, so he was prescribed topical therapy with tirbanibulin 1% ointment. After 10 days erythema and crusts were objectified and a burning sensation was reported on the area of application and on surrounding areas. At 8 weeks follow-up, the patient had total resolution of disease and no residual local side effects. Although tirbanibulin 1% ointment has indication for type I AKs of face and scalp, this case reported its efficacy and benefit also on type II AKs, demonstrating safety and a minimal and manageable degree of discomfort caused to the patient. Therefore, it fits fully among the treatments of grade I AKs but numerous still may be its indications as demonstrated in our case, where efficacy, safety and compliance were combined.

摘要

光化性角化病(AK)是常见的癌前病变,通常出现在长期暴露于阳光下的区域。癌变场(FC)是一个长期暴露于紫外线的区域,在其中可发现亚临床多灶性AK。治疗选择主要根据AK的奥尔森分级来做出。我们报告了一名76岁男性面部和头皮有大量AK的病例。该患者接受了多次局部物理和药物治疗,但效果不佳。在左脸颊,在一个大的FC区域发现了I级和II级AK,因此给他开了1%替巴尼布林软膏的局部治疗。10天后观察到红斑和结痂,患者报告在用药部位及周围区域有烧灼感。在8周的随访中,患者疾病完全消退,且无残留局部副作用。虽然1%替巴尼布林软膏适用于面部和头皮的I型AK,但本病例报告了其对II型AK也有效且有益,证明了其安全性以及给患者带来的不适程度最小且可控。因此,它完全适合I级AK的治疗,但正如我们病例所示,其适应证可能仍然很多,在该病例中疗效、安全性和依从性得到了结合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验